Drug Interaction Report

Nadolol and Epinephrine: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Nadolol

Corgard Corgard®
+

Epinephrine

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 195 documented Nadolol interactions, 41 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
rapid
Evidence
established
Severity
Major

What happens

Antagonized cardio stimulating, bronchodilation effects of EPINEPHrine, increased risk of hypertension, increased risk of bradycardia and resistance to EPINEPHrine in anaphylaxis

Interaction Deep Dive

Avoid the concomitant use of EPINEPHrine, a sympathomimetic agent, and nadolol, a nonselective beta-adrenergic antagonist, as it may result in severe and prolonged hypertension. Closely monitor the patient if concurrent therapy is necessary1. A controlled study demonstrated that EPINEPHrine, when given to patients taking nadolol, resulted in increased diastolic blood pressure and decreased heart rate 10. Nonselective beta-blockers block the beta effects of EPINEPHrine, resulting in unopposed alpha effects 11. Nadolol may also cause resistance to EPINEPHrine in cases of anaphylaxis 12. Glucagon has been effective in cases of resistant anaphylactic shock 3.

Why it happens (mechanism)

Unknown; unopposed alpha-receptor stimulation

Literature reports

5 reports — tap to read

a) Following inhalation therapy with EPINEPHrine, concurrent propranolol administration may inhibit EPINEPHrine-induced bronchodilatation (mediated through beta-2 receptors) and increase the patient's blood pressure (due to unopposed alpha stimulation), especially if the EPINEPHrine dose is repeated. EPINEPHrine failed to reverse an anaphylactic reaction to a maintenance allergy injection in a patient on chronic oral propranolol. Intubation, neuromuscular blockade, antihistamine, and steroids were used during supportive care 4. Cardioselective beta blockers (atenolol, metoprolol, acebutolol), however, appear to have little effect on the pressor response to EPINEPHrine and low doses are not likely to interfere with EPINEPHrine-induced bronchodilatation. The effect of larger doses on bronchodilatation produced by EPINEPHrine is not well studied at this time 5.

b) Acute hypertension followed by a reflex bradycardia can occur during combined propranolol (or other nonselective beta-blockers) and EPINEPHrine therapy 67. The hypertensive effect is related to blocking of beta-receptors resulting in alpha-receptor dominance and a paradoxical hypertension. Bradycardia represents a secondary reflex cardiac response mediated by vagally-innervated aortic arch and carotid baroreceptors. Propranolol results in this latter effect by inhibiting the ability of the cardiovascular system to respond appropriately to this added stress. Elevated peripheral resistance increases the work load of the myocardium, and it is unable to be stimulated to increase its output, thus resulting in reflex bradycardia. This sequence of events may result in cardiac arrest or hypertensive stroke 87.

c) Propranolol pretreatment followed by EPINEPHrine infusion was reported to lower the pulse rate to 30 beats per minute with first- and second-degree AV block in a healthy 22-year-old male 7. In 4 hypertensive patients and 5 normal subjects, EPINEPHrine alone (0.4 mg subcutaneously) produced an increase in heart rate and minimal effects on blood pressure; but with propranolol pretreatment (40 mg orally), EPINEPHrine produced a 20 to 40 mmHg rise in blood pressure and a 23 to 26 beats per minute decrease in heart rate 9.

d) An interaction was demonstrated in a hemodynamic study evaluating the effect of low-dose EPINEPHrine (in an attempt to simulate situations of daily life stress) on patients receiving either propranolol or metoprolol. EPINEPHrine was infused at graded rates of 0.5, 1, 2, and 4 mcg/min, with each dose sustained for 8 minutes. While the hypertensive patients were maintained on propranolol 80 mg/day, low-dose EPINEPHrine infusion caused a marked rise in systolic as well as diastolic blood pressure and decreases in heart rate. However, when patients were maintained on metoprolol 100 mg daily, EPINEPHrine infusion induced only a slight rise in blood pressure and an increase in heart rate. The effect of epinephrine may have relevance in the choice of which beta-blocker should be used for the treatment of hypertension. Metoprolol, because it is selective for beta-1 receptor blockade, appears to be a better choice than propranolol in the treatment of hypertension 6.

e) In a controlled study of 10 healthy male volunteers, the effects of nonselective beta-blockers on pressor responsiveness to EPINEPHrine, norepinephrine, and angiotensin II were studied. Pressor responses were recorded after placebo and after subjects were given nadolol or propranolol 240 mg per day for 4 weeks. After placebo, EPINEPHrine lowered diastolic blood pressure and raised heart rate. After treatment with a beta-blocker, EPINEPHrine raised diastolic blood pressure and lowered heart rate. Beta-blockade also increased subject pressor response to norepinephrine; 35% less norepinephrine was required to raise mean blood pressure by 15 mmHg 10.

Common questions

Can I take Nadolol and Epinephrine together?

Antagonized cardio stimulating, bronchodilation effects of EPINEPHrine, increased risk of hypertension, increased risk of bradycardia and resistance to EPINEPHrine in anaphylaxis Always confirm with your pharmacist or prescriber before making any change.

How serious is the Nadolol and Epinephrine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Questions for your pharmacist

  • Does my dose of Nadolol or Epinephrine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (12)

  1. Product Information: Septocaine(R) Solution for intraoral submucosal injection, articaine hydrochloride 4% and epinephrine 1:200,000 articaine hydrochloride 4% and epinephrine 1:100,000 Solution for intraoral submucosal injection. Septodont, Lousiville, CO, 2009. DailyMed
  2. Product Information: NEFFY(R) nasal spray, epinephrine nasal spray. ARS Pharmaceuticals Operations, Inc. (per FDA), San Diego, CA, 2024. DailyMed
  3. None Listed: The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115(3 Suppl):S483-S523. PubMed
  4. Newman BR & Schultz LK: Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride. Ann Allergy 1981; 47:35-37.
  5. Pollack CV Jr: Utility of glucagon in the emergency department. J Emerg Med 1993; 11:195-205. PubMed
  6. Houben H, Thien T, & van't Laar A: Effect of low dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Clin Pharmacol Ther 1982; 31:685-690.
  7. Kram J, Bourne HR, Melmon KL, et al: Propranolol (letter). Ann Intern Med 1974; 80:282.
  8. Foster CA & Aston SJ: Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg 1983; 72:74-78. PubMed
  9. Varma DR, Shama KK, & Arora RC: Response to adrenalin and propranolol in hyperthyroidism. Lancet 1976; 1:260.
  10. Reeves RA, Boer WH, DeLeve L, et al: Nonselective beta-blockade enhances pressor responsiveness to epinephrine, norepinephrine, and angiotensin II in normal man. Clin Pharmacol Ther 1984; 35:461-466. DOI
  11. Gandy W: Severe epinephrine-propranolol interaction. Ann Emerg Med 1989; 18:98-99.
  12. Awai LE & Mekori YA: Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication. Ann Allergy 1984; 53:48-49.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.